Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4 Lymphoid 3 Other hematologic neoplasm 2 Thoracic 1 NET 1 Myeloid 1 Endocrine 1

Conditions

Interventions

Carboplatin 1170 Cisplatin 890 Pemetrexed 845 pembrolizumab 624 Paclitaxel 608 Docetaxel 539 Gemcitabine 428 Radiotherapy 390 Erlotinib Hydrochloride 381 Nivolumab 344 Bevacizumab 337 Etoposide 296 durvalumab 264 Drug Therapy 260 osimertinib 236 atezolizumab 224 Radiosurgery 194 Gefitinib 186 Vinorelbine 149 Magnetic Resonance Spectroscopy 131 Ipilimumab 129 130-nm albumin-bound paclitaxel 125 Cetuximab 113 Blood Specimen Collection 106 anlotinib 105 tislelizumab 103 Topotecan 103 Specimen Handling 102 Surgical Procedures, Operative 101 Cyclophosphamide 101

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

68Ga-pentixafor × Thoracic × Clear all

NCT06086327 2023-10-17

Application of 68Ga-Pentixafor PET/CT for Thymoma

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡